phospho-eIF4E (Ser209) Recombinant Antibody

Applications

  • WB
  • IHC-P
  • IHC-F
  • IF
  • ICC/IF

Reactivity

  • Human
  • Mouse
  • Rat
Overview
Catalog # bsm-52152r
Product Name phospho-eIF4E (Ser209) Recombinant Antibody
Applications
WB IHC-P IHC-F IF ICC/IF
Reactivity Human, Mouse, Rat
Specifications
Conjugation Unconjugated
Host Rabbit
Source KLH conjugated Synthesised phosphopeptide derived from human eIF4E around the phosphorylation site of Ser209
Modification Site S209
Clonality Recombinant
Clone # 2B1
Isotype IgG
Concentration Lot Dependent
Purification purified by Protein A.
Storage Buffer 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID 1977
Swiss Prot P06730
Subcellular location Cytoplasm, Nucleus
Synonyms AUTS19; CBP; EIF4E1; EIF4EL1; EIF4F; eIF-4E; EG668879; Eif4e-ps; If4e; IF4E_HUMAN; EIF4E; eIF-4F 25 kDa subunit; mRNA cap-binding protein; IF4E_MOUSE; IF4E_RAT; eukaryotic translation initiation factor 4E; eIF4E (phospho-S209); p-eIF4E; phospho-eIF4E; eIF4E (phospho-Ser209)
Background Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures. Component of the CYFIP1-EIF4E-FMR1 complex which binds to the mRNA cap and mediates translational repression. In the CYFIP1-EIF4E-FMR1 complex this subunit mediates the binding to the mRNA cap.
Application Dilution
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500
IF
ICC/IF 1:50-100